Compare Fox Corp Class B (FOX) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Fox Corp Class B trades at $55.56 (market cap $24.91B), while GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Fox Corp Class B pays the higher dividend (1.04%). Which is the better fit depends on your goals.
| FOX | GEHC | |
|---|---|---|
Market Cap | $24.91B | $31.07B |
Volume | 395,394 | 3,443,020 |
Sector | Media | Health |
52-Week High | $67.76 | $88.16 |
52-Week Low | $44.39 | $59.48 |
Typical Hold Time | 75 Days | — |
Enterprise Value | $28.27B | $39.53B |
Dividend Yield | 1.04% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOX trades at $55.68, down 0.54% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.79 exceeding the $1.44 estimate. Fundamentals show robust revenue growth to $16.30 billion in 2025 and a net income margin of 13.88%. Analyst consensus is a Buy with a $84.75 price target, implying significant upside, though cash flow projections for 2026 indicate a potential net outflow.
The outlook for FOX is positive based on solid fundamentals and analyst optimism, but risks include a projected net cash flow deficit in 2026 and competitive pressures in the media sector. The stock presents a value opportunity with a P/E of 14.56 trading below the analyst target, yet investors should monitor execution against future earnings expectations and industry headwinds.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
